Mozobil ® Solution

    Mozobil ® Solution

    S4

    API: Plerixafor | Company: Sanofi-Aventis

    1. WHAT MOZOBIL ® IS AND WHAT IT IS USED FOR

    MOZOBIL ® works by helping your bone marrow release stem cells into your bloodstream so they can be collected and transplanted back into the body. MOZOBIL ® is used in people with non-Hodgkin's lymphoma or multiple myeloma.

    2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE/USE MOZOBIL ®

    Do not use MOZOBIL ® if you are allergic to plerixafor or to any of the components of MOZOBIL ® (see WHAT MOZOBIL ® CONTAINS).

    Take special care with MOZOBIL ®

    • Do not use MOZOBIL ® if you have leukemia.
    • Before you take MOZOBIL ®, tell your doctor if you have kidney disease.
    • To be sure MOZOBIL ® is not causing harmful effects, your blood will need to be tested often.

    Pregnancy and breastfeeding: DO NOT use MOZOBIL ® if you are pregnant, planning to become pregnant or breastfeeding. Please contact your doctor immediately if you suspect you are pregnant.

    Driving and using machines: MOZOBIL ® is not expected to affect your ability to drive a car or operate machinery. Do take care until you know how this medicine affects you.

    Using other medicines with MOZOBIL ®: If you are taking other medicines on a regular basis, including complementary or traditional medicines, the use of MOZOBIL ® with these medicines may cause undesirable interactions. Consult your doctor or pharmacist if you are taking any other medicines, including any you have bought at your pharmacy, supermarket or health food shop.

    3. HOW TO TAKE/USE MOZOBIL ®

    MOZOBIL ® is given as an injection under the skin and will only be administered in a hospital or clinic setting by your healthcare professional. Your doctor will decide on the correct dose and how long the treatment will be based on your body mass and condition to obtain the required result.

    Before receiving MOZOBIL ®, you will be given another medication that will help your bone marrow produce stem cells and certain white blood cells that help support your immune system.

    In the event of an overdosage Your doctor will administer this medicine and will closely monitor your response and condition and control the dosage. In the unlikely event of overdosage, your doctor will treat the side effects symptomatically.

    If you forget to use your MOZOBIL ® Your doctor will ensure you receive MOZOBIL ® at the correct time. If you are concerned that you may have missed a dose, contact your doctor immediately.

    4. POSSIBLE SIDE EFFECTS

    MOZOBIL ® may have side effects. If you experience the following, please consult your doctor immediately, as you may have had an allergic reaction to MOZOBIL ®:

    • Irregular heart beat
    • Allergic reactions (swelling of the hands, feet, ankles, face, lips, mouth, or throat which may cause difficulty in swallowing or breathing, severe skin rashes)

    The following common to very common side effects may occur:

    • Headache, dizziness, insomnia
    • Diarrhoea, constipation, nausea, vomiting
    • Flatulence, stomach pain, stomach discomfort, bloatedness, indigestion
    • Dry mouth, the loss of sensitivity to pain or touch
    • Excessive sweating
    • Redness of the skin, pain and swelling at the site where MOZOBIL ® was injected
    • Joint pain, pain of the muscles, tendons, ligaments and bones, tiredness, a feeling of general discomfort or uneasiness

    Not all side effects reported for MOZOBIL ® are included in this leaflet. Should your general health worsen while using this medicine, please consult your doctor for advice.

    5. HOW TO STORE MOZOBIL ®

    Store at or below 25 °C. For single use only. Discard any unused portion. From a microbiological point of view, once drawn into a syringe, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user.

    KEEP ALL MEDICINE OUT OF REACH OF CHILDREN.

    Important Disclaimer

    The Mozobil ® Solution professional information leaflet below is the property of Sanofi-Aventis and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Mozobil ® Solution
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites